INTRAOSSEOUS INFUSION DEVICES MARKET ANALYSIS

Intraosseous Infusion Devices Market, By Product Type (FAST 1 Device, FAST x Device, Bone Injection Gun (BIG) Devices, EZ-IO Device, NIO Device, Dieckmann Modified Needle, Jamshidi Needle), By Technology (Manual IO Needles, Battery Powered Driver, Impact Driven Devices), By End User (Hospitals, Clinics, Ambulatory Surgical Centers, Others (Pre-hospital Emergency Care, Military Hospitals, etc.)), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

Published In : Nov 2023
Code : CMI507
Pages :193
Formats :
Excel and PDF
Industry : Medical Devices

Leading Companies

Global Intraosseous Infusion Devices Market- Cross Sectional Analysis:

Key players are manufacturing intraosseous infusion devices with advanced technology in emerging economies owing to growing incidences of cardiovascular diseases and road accidents, which is driving the overall intraosseous infusion devices market across North America. For instance, in 2022, according to the data published by MedScape, in U.S., the incidence of femoral shaft fractures ranges from 9.5 to 18.9 per 100,000 annually. Moreover, approximately 250,000 proximal femur fractures occur in the U.S. annually.

Global Intraosseous Infusion Devices Market - Key Players

Major players operating in the global intraosseous infusion devices market include PerSys Medical, Aero Healthcare AU Pty Ltd, Teleflex Incorporated, PAVmed Inc., Becton Dickinson Company, BIOPSYBELL S.R.L., Cook Group, SAM Medical, Argon Medical Devices, Inc., Cardinal Health, Inc., StarFish Product Engineering Inc., and Medax SRL unipersonle.